Melissa Baird Sells 11,750 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock

Hims & Hers Health, Inc. (NYSE:HIMS) COO Melissa Baird sold 11,750 shares of Hims & Hers Health stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.08, for a total value of $141,940.00. Following the sale, the chief operating officer now directly owns 538,932 shares in the company, valued at approximately $6,510,298.56. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Melissa Baird also recently made the following trade(s):

• On Monday, April 8th, Melissa Baird sold 11,751 shares of Hims & Hers Health stock. The shares were sold at an average price of $14.74, for a total value of $173,209.74.
• On Friday, April 5th, Melissa Baird sold 11,751 shares of Hims & Hers Health stock. The shares were sold at an average price of $14.58, for a total value of $171,329.58.
• On Wednesday, March 6th, Melissa Baird sold 11,751 shares of Hims & Hers Health stock. The shares were sold at an average price of $13.99, for a total value of $164,396.49.

Hims & Hers Health Stock Performance

Shares of NYSE HIMS opened at $11.26 on Friday. The stock’s fifty day simple moving average is $14.01 and its 200 day simple moving average is $10.25. Hims & Hers Health, Inc. has a 52-week low of $5.65 and a 52-week high of $17.16.

Hims & Hers Health (NYSE:HIMS) last issued its earnings results on Monday, February 26th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.03. Hims & Hers Health had a negative return on equity of 7.21% and a negative net margin of 2.70%. The business had revenue of $246.60 million for the quarter, compared to analysts’ expectations of $245.84 million. During the same period in the previous year, the firm posted ($0.05) EPS. The company’s quarterly revenue was up 47.4% on a year-over-year basis. Analysts predict that Hims & Hers Health, Inc. will post 0.11 EPS for the current year.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Jefferies Financial Group reaffirmed a “hold” rating and set a $15.00 target price (down previously from $17.00) on shares of Hims & Hers Health in a research note on Tuesday, April 16th. Canaccord Genuity Group began coverage on Hims & Hers Health in a research report on Wednesday, April 10th. They set a “buy” rating and a $20.00 price target on the stock. Citigroup lifted their price target on Hims & Hers Health from $12.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, February 27th. TheStreet upgraded Hims & Hers Health from a “d” rating to a “c” rating in a research report on Monday, March 4th. Finally, Truist Financial lifted their price target on Hims & Hers Health from $10.00 to $13.00 and gave the company a “hold” rating in a research report on Tuesday, February 27th. Five analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $14.85.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of HIMS. SG Americas Securities LLC purchased a new position in shares of Hims & Hers Health during the third quarter valued at $280,000. Bank of New York Mellon Corp grew its holdings in shares of Hims & Hers Health by 11.5% during the third quarter. Bank of New York Mellon Corp now owns 564,501 shares of the company’s stock valued at $3,551,000 after buying an additional 58,288 shares in the last quarter. Mackenzie Financial Corp grew its holdings in shares of Hims & Hers Health by 354.2% during the third quarter. Mackenzie Financial Corp now owns 51,243 shares of the company’s stock valued at $318,000 after buying an additional 39,962 shares in the last quarter. Strs Ohio grew its holdings in shares of Hims & Hers Health by 33.0% during the third quarter. Strs Ohio now owns 102,000 shares of the company’s stock valued at $641,000 after buying an additional 25,300 shares in the last quarter. Finally, Teacher Retirement System of Texas grew its holdings in shares of Hims & Hers Health by 7.4% during the third quarter. Teacher Retirement System of Texas now owns 72,253 shares of the company’s stock valued at $454,000 after buying an additional 4,954 shares in the last quarter. Hedge funds and other institutional investors own 63.52% of the company’s stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.